Comment
doi: 10.1016/S0140-6736(16)32516-8.
Epub 2016 Dec 8.
Immune-checkpoint blockade in cisplatin-ineligible patients with urothelial cancer
Affiliations
- PMID: 27939401
- DOI: 10.1016/S0140-6736(16)32516-8
Item in Clipboard
Comment
Immune-checkpoint blockade in cisplatin-ineligible patients with urothelial cancer
Lancet.
.
No abstract available
Comment on
-
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial.Lancet. 2017 Jan 7;389(10064):67-76. doi: 10.1016/S0140-6736(16)32455-2. Epub 2016 Dec 8. Lancet. 2017. PMID: 27939400 Free PMC article. Clinical Trial.
Similar articles
-
New option for cisplatin-ineligible urothelial cancer.Lancet Oncol. 2017 Nov;18(11):1428-1430. doi: 10.1016/S1470-2045(17)30602-2. Epub 2017 Sep 26. Lancet Oncol. 2017. PMID: 28967486 No abstract available.
-
Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder.Cancer. 2006 Aug 1;107(3):506-13. doi: 10.1002/cncr.22031. Cancer. 2006. PMID: 16773629
-
Pembrolizumab for the treatment of bladder cancer.Expert Rev Anticancer Ther. 2018 Feb;18(2):107-114. doi: 10.1080/14737140.2018.1421461. Epub 2017 Dec 29. Expert Rev Anticancer Ther. 2018. PMID: 29284318 Review.
-
First-line treatment of metastatic disease: cisplatin-ineligible patients.Hematol Oncol Clin North Am. 2015 Apr;29(2):329-40, x. doi: 10.1016/j.hoc.2014.10.006. Epub 2014 Dec 15. Hematol Oncol Clin North Am. 2015. PMID: 25836938 Review.
-
Atezolizumab in urothelial bladder carcinoma.Future Oncol. 2018 Feb;14(4):331-341. doi: 10.2217/fon-2017-0433. Epub 2017 Nov 14. Future Oncol. 2018. PMID: 29135284 Review.
Cited by
-
Co-stimulatory agonists: An insight into the immunotherapy of cancer.EXCLI J. 2021 Jun 9;20:1055-1085. doi: 10.17179/excli2021-3522. eCollection 2021. EXCLI J. 2021. PMID: 34267616 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
